Position in LKFT
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,964,379
+$354,549 QoQ
Shares Held
65,523
+22.1% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 78 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. LKFT ranks #42 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in LKFT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,964,379 | 65,523 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,609,830 | 53,661 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,758,965 | 53,791 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,105,189 | 31,905 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $990,230 | 35,378 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,212,944 | 48,286 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,470,012 | 53,455 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,436,563 | 49,898 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,274,955 | 51,451 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,504,126 | 46,712 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,858,599 | 45,722 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,669,179 | 48,312 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,956,599 | 48,121 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,663,645 | 43,055 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,980,945 | 44,636 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,543,695 | 36,203 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,185,351 | 39,164 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,165,387 | 67,162 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,205,316 | 76,280 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||